Upregulation of miR150-5p in generalized myasthenia gravis patients is associated with decreased serum levels of IL-17 and increased serum levels of IL-10
Open Access
- 26 March 2020
- journal article
- research article
- Published by Palacky University Olomouc in Biomedical Papers
- Vol. 164 (1), 57-62
- https://doi.org/10.5507/bp.2019.009
Abstract
Background. MiR150-5p has been reported to be involved in generalized myasthenia gravis, in which different cytokines play critical roles. The regulatory network of cytokines in generalized myasthenia gravis has not been fully elucidated. Our study aimed to investigate the interactions between miR150-5p and different cytokines in generalized myasthenia gravis. Materials and Method. Serum levels of miR150-5p and different cytokines including IL-2, IL-17, IL-10, IL-19, IL-20 and IL-35 were detected by qRT-PCR and ELISA, respectively. ROC curve analysis was performed to evaluate the diagnostic value of miR150-5p for generalized myasthenia gravis. Correlation between serum levels of miR150-5p and different cytokines were analyzed by Pearson correlation coefficient. Results. Compared with healthy controls, decreased serum levels of IL-2 and IL-17 and increased serum levels of miR150-5p, IL-10, IL-19, IL-20 and IL-35 were observed in patients with generalized myasthenia gravis. Serum levels of miR150-5p were positively correlated with IL-10 and negatively correlated with IL-17. After treatments, serum levels of miR150-5p and IL-10 decreased, while serum levels of IL-2 and IL-17 increased. Conclusion. Upregulation of miR150-5p is involved in generalized myasthenia gravis patients and is associated with decreased serum levels of IL-17 as well as increased serum levels of IL-10.Keywords
This publication has 19 references indexed in Scilit:
- An overview of microRNAsAdvanced Drug Delivery Reviews, 2015
- Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSKPLOS ONE, 2015
- Genetic basis of myasthenia gravis – A comprehensive reviewJournal of Autoimmunity, 2014
- Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanismsJournal of Autoimmunity, 2014
- Analysis of Serum miRNA Profiles of Myasthenia Gravis PatientsPLOS ONE, 2014
- Central role of interferon-beta in thymic events leading to myasthenia gravisJournal of Autoimmunity, 2014
- Circulating miRNAs in myasthenia gravis: miR‐150‐5p as a new potential biomarkerAnnals of Clinical and Translational Neurology, 2013
- Identification of Novel MicroRNA Signatures Linked to Experimental Autoimmune Myasthenia Gravis Pathogenesis: Down-Regulated miR-145 Promotes Pathogenetic Th17 Cell ResponseJournal of Neuroimmune Pharmacology, 2013
- The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravisBlood, 2006
- MicroRNAs: Genomics, Biogenesis, Mechanism, and FunctionCell, 2004